S 1123 117th Congress Senate Health Competition and antitrust Health care costs and insurance Inflation and prices Medicare Prescription drugs

PING Act

Introduced: April 14, 2021 Introduced by: Blackburn, Marsha Republican · Tennessee See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Apr 14, 2021

Read twice and referred to the Committee on Finance.

Apr 14, 2021

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Preserving Innovation for the Next Generation Act or the PING Act

This bill expresses the sense of the Senate that the current restrictions prohibiting the Centers for Medicare & Medicaid Services from negotiating the prices or establishing a formulary for drugs under the Medicare prescription drug benefit should not be repealed. The bill also prohibits the Center for Medicare and Medicaid Innovation from testing any model that would repeal or require a waiver of such restrictions.

What's happening now April 14, 2021

Read twice and referred to the Committee on Finance.

Bill text 1 version